The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
[Recorded May 7, 2020]
Eric J. Grigsby, MD, MBA and NANS Board Member, Stephanie G. Vanterpool, MD, MBA review exploring NANS’ Neuromodulation Device Algorithm for COVID-19.
This guidance refers to the management of currently implanted neuromodulation devices. With rare exception, implantation of new devices is considered elective in the current COVID-19 environment.
This nonaccredited educational webinar is provided for information only.
You must be logged in and own this session in order to